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Efficacy and safety of single-trocar technique for minimally
invasive surgery of the chest in the treatment of
noncomplex pleural disease
Marcello Migliore, MD, PhD, FETCS
Objective: To assess the efficacy and the safety of a single-trocar technique for
minimally invasive surgery of the chest in the management of multiple non-
complex thoracic diseases, a prospective study was performed and the results are
presented.
Methods: Between October 1998 and December 2001, 100 patients underwent
video-assisted thoracic surgery through a single trocar. The patients were divided
into 4 groups as follows: (1) benign, (2) malignant, (3) pleural effusion, and (4)
empyema. The following data were analyzed: age, sex, forced vital capacity, forced
expiratory volume in 1 second, percentage of the predicted forced expiratory volume
in 1 second, type of anesthesia, anesthesia time, surgery time, intraoperative com-
plications, morbidity, chest tube removal, hospital stay, and follow-up.
Results: The patient population consisted of 64 men and 36 women with a mean age
of 62 years (range 31-92 years). General anesthesia was used in 53 patients (25
double-lumen and 28 single-lumen tube) and local anesthesia and sedation in 47
patients. Talc pleurodesis was performed in 55 patients. Mean operative time was 65
 37 minutes, 48  18 minutes for simple and 67  37 minutes (P  .004) for
complex pleural effusion. Mean anesthesia time was 102 85 minutes. Chest tubes
were removed after 5  2 days. Mean overall hospital stay was 6  3 days, 5  2
days for benign diseases, 7  3 days for malignant diseases, and 8  3 for
empyema. Morbidity was present in 19 patients. Two patients had intraoperative
bleeding; 1 required a mini-thoracotomy to control it. There was no hospital
mortality. Three patients had wound infection, and no patient with malignant
diseases had port site metastasis.
Conclusion: Video-assisted thoracic surgery through a single trocar is simple,
effective, and beneficial for all patients in the diagnosis and treatment of noncom-
plex diseases of the chest. Furthermore, with this newest type of technologically
advanced instrumentation it is possible to carry out simple intrathoracic procedures
without using additional ports.
Thoracic surgeons are aware that video-assisted thoracic surgery(VATS) is not an operation but rather an approach to performoperations. The standard thoracoscope is the instrument most com-monly used to perform diagnostic procedures in the pleural cavity;recently some minimally invasive techniques have improved thedisadvantages of the classic thoracoscope.1-4
Based on my institution’s experience of using different ports available for VATS,
an easy and reproducible minimally invasive technique was recently developed,4
which is defined as VATS through a single trocar (VATS-st).5 The technical
advantages of the technique over the standard thoracoscopy or the use of video-
mediastinoscope have been reported.4
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To assess the results and safety of VATS-st in the man-
agement of multiple noncomplex pathologies of the chest, I




Between October 1, 1998, and August 31, 2001, 100 patients
underwent VATS-st at the General Thoracic Surgery department at
the University of Catania, in Catania, Italy. All patients had a
thorough preoperative workup including medical history, chest
radiography in 2 planes, respiratory function tests (RFTs), and
electrocardiography. Thoracocentesis, examination with a flexible
bronchoscope, computed tomographic scan of the chest and upper
abdomen and brain, and bone scintigraphy were performed when
appropriate.
The following parameters were analyzed: age, sex, forced vital
capacity (FVC), forced expiratory volume in 1 second (FEV1),
percentage of the predicted forced expiratory volume in 1 second
(% FEV1), type of anesthesia, anesthesia time, operative time,
intraoperative complications, morbidity, chest tube removal, hos-
pital stay, and follow-up.
To demonstrate the safety and efficacy of this technique in
different diseases of the chest, the patients were divided into 4
groups as follows: (1) benign, (2) malignant, (3) pleural effusion,
and (4) empyema.
The type of anesthesia and the use of a single- or double-lumen
tube were chosen according to the general condition of the patient
defined by the American Society of Anesthesiology (ASA) score
and the pathology. Informed consent was obtained from each
patient.
Patient Selection and Definitions
Patients were selected on the basis of a preliminary diagnosis of
noncomplex thoracic disease. Noncomplex thoracic disease was
defined as a disease of the chest that did not require an extensive
dissection. Complex pleural effusion was used to identify an
effusion characterized by multiple loculated pockets of fluid. An-
esthesia time was the time interval between the entrance and the
exit of the patient from the operating room. Surgery time was
defined as the time interval between the skin incision and closure.
The success rate of talc pleurodesis in pleural effusion was defined
as absence of recurrence of pleural effusion within 30 days. The
term “trapped lung” was used when pleural effusion was associ-
ated with thickness of the visceral pleura incarcerating the entire
lung, and “trapped lobe” was used when the thick visceral pleura
incarcerated only a lobe or segments of the lung.
Operative Instrumentations
The trocars commercially available for use are flexible (Flexipath,
Ethicon, Inc, Somerville, NJ) and soft (Soft Thoracoport, Tyco
International Ltd, Bermuda) with diameters ranging from 15 to 20
mm. These characteristics allow the simultaneous introduction of
the optic instrument and 1 or 2 standard 5-mm thoracoscopic
instruments. A 0° or 45° oblique viewing telescope of 5 or 10 mm
can be used according to the disease. In this study, all types of
5-mm mini-invasive thoracoscopic instruments, including a com-
bined suction and irrigating system, rotating scissors and graspers,
5-mm clip appliers, dissecting tampons, and ultrasound devices,
were used. In some instances, standard open surgical instruments
are useful.
Anesthesia
General anesthesia was chosen in 53 patients. Twenty-five patients
had a double-lumen endotracheal tube to allow total collapse of the
ipsilateral lung, and 28 patients had a standard endotracheal tube.
Forty-seven patients had local anesthesia and sedation as previ-
ously described.6 Figure 1 reports the ASA scores.
VATS-st Technique
The surgical team included a primary surgeon, a first assistant, and
a scrub nurse. The surgical technique was previously described.4
The patient was placed in the standard posterolateral decubitus
position, but according to the specific location of the lesion and
general condition, the operation was sometimes performed with
the patient in the supine or anterolateral position. A 2-cm skin
incision was performed in the planned intercostal space and the
parietal pleura was opened under direct vision to 4 or 5 cm. The
index finger was used to lyse the possible adhesions of the lung to
the chest wall, and the trocar was always inserted by means of a
Kelly clamp. Once the trocar was positioned through the intercos-
tal muscles, it became oval with the maximal diameter along the
intercostal space; this structural modification was more evident on
the pleural side. For improved flexibility and the ability to maneu-
ver the instruments, a pyramid was created with a base in the
pleura and the apex in the skin.
The chest drain was inserted under visual control. Postopera-
tively, chest radiographs were taken daily to ensure full lung
expansion and to check for any pneumothorax or residual effusion.
The chest drainage was under suction for at least 24 hours, and the
tube was removed the day after the procedure or when the drainage
was less than 100 mL daily.
Statistical Analysis
Demographic data are reported as mean  SD. We used the
Student t test for parametric results and the Mann-Whitney rank-
Figure 1. ASA status of the study group. PE, Pleural effusion.
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sum test and Kruskal-Wallis tests for nonparametric comparisons,
while ordinal data were compared using the 2 test.
Results
Patients Demographics
There were 64 male and 36 female patients with a mean age
of 62  13 years (range 31-92 years). The indications for
the procedure in the 100 patients are reported in Table 1.
Respiratory function tests showed an FVC of 2.2  0.83
(range 0.88-4.17) and an FEV1 of 1.55  0.64 (range
0.38-3.35); mean % FEV1 was 66%  20% (range 24%-
124%). Twenty patients had FEV1 less than 50%. Undiag-
nosed pleural effusion after thoracocentesis was present in
16 patients. A known history of lung cancer was present in
16 patients, breast cancer in 9 patients, and thymoma, non-
Hodgkin lymphoma, laryngeal cancer, left kidney cancer,
bladder cancer in 1 patient each.
Outcome of the Operations
There were 2 instances of intraoperative bleeding (2%). One
patient required a 5-cm mini-thoracotomy and the other a
simple compression. In 4 cases (4%) it was necessary to
insert another trocar. During some phases of the operation,
2 surgical instruments were always used simultaneously
with the optic. Trapped lobe was present in 9 and trapped
lung in 4 patients. Mean operative time was 65  37
minutes (range 20-195 minutes) and mean anesthesia time
was 102 85 minutes. Chest tubes were removed after 5
2 days (range 2-14 days). Hospital stay was 6  3 days
(range 2-15 days). Histologic studies was conducted in 95
patients as shown in Table 2. In 5 patients pleural biopsy
was not performed because no macroscopic lesions were
present. Morbidity was present in 19 patients (19%). Atrial
fibrillation, air leak, and hyperpyrexia were noted to be
related to morbidity. Three patients had wound infection
and no patients with malignant diseases had port site me-
tastasis. There was no hospital mortality. Follow-up was
complete with a mean of 11  8 months.
Benign Diseases
There were 30 patients with benign disease (20 men, 10
women) with a mean age of 60 years (range 43-89 years).
All patients with empyema were excluded. Hepatic cirrhosis
was present in 5 patients. Three patients had clotted hemo-
thorax. Surgery time was 57  39 minutes (range 20-180
minutes) and anesthesia time was 95  66 minutes (range
30-275 minute). Mean time of chest tube removal was 4 
2 days (range 2-11 days) and hospital stay was 5  2 days
(range 2-12 days). There were no intraoperative complica-
tions and morbidity was 8%. Talc pleurodesis was per-
formed in 4 patients older than 80 years.
Malignant Diseases
There were 55 patients with malignant disease (33 men, 22
women) with a mean age of 64  11 years (range 32-89
years). One patient had a large mediastinal mass simulta-
neously with a left pleural effusion (Figure 2). Surgery time
was 59 27 minutes (range 20-140 minutes) and anesthesia
time was 102  45 minutes (range 30-225 minutes). In 4
patients with trapped lung an indwelling pleural catheter
was inserted. Chest tubes were removed at 5  2 days
(range 2-9 days) and hospital stay was 6  2 days (range
2-10). Morbidity was present in 12 (22%) patients (atrial
fibrillation and hyperpyrexia). Talc pleurodesis was per-
formed in 51 patients with a success rate of 90% (46
patients).
Pleural Effusion
There were 67 patients with pleural effusion: 34 of them had
simple effusion (19 men and 15 women) with a mean age of
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62  12 years and 33 patients had complex effusion (19
men and 14 women) (Figure 3, A and B) with a mean age of
61  15 years. Surgery time was 48  18 minutes for
simple and 67  37 minutes for complex effusion (P 
.004). Anesthesia time was 83  37 and 115  55 minutes,
respectively (P .005). Chest tubes were removed at 5.1
1.8 for simple and 4.8  2.4 for complex pleural effusion,
and hospital stay was 7  3 versus 6  3 days. Pleurodesis
was performed in 29 patients with simple and 11 patients
with complex pleural effusion.
Empyema
There were 15 patients (10 men, 5 women) with a final
diagnosis of stage II empyema with a mean age of 65  15
years (range 16-92 years). Eight patients underwent surgery
under local anesthesia and sedation and 7 patients under
general anesthesia (2 patients with a single- and 4 patients
with a double-lumen tube). The flexible trocar was placed
through the latissimus dorsi in 3 patients. One patient had a
“simple” pleural empyema after pneumonectomy. One pa-
tient with empyema, following repeated thoracocentesis,
had a mesothelioma (Figure 3, A and B). One patient had an
empyema complicating a hemothorax. In 2 patients “decor-
tication” of a lobe was performed. In 2 cases it was neces-
sary to insert another trocar. One patient had a prolonged air
leak (7 days). Surgery time was 75.7  18.8 minutes.
Anesthesia time was 115  72.3 minutes. Chest tubes were
removed at 7.4  3.7 days and hospital stay was 7.8  3.1
days. No patient had recurrence of empyema.
Discussion
In the past decade, VATS gained popularity because of its
minimally invasive technique. Rusch and Mountain1 de-
scribed the advantages of a mediastinoscope to diagnose
and treat pleural diseases. Ozuner and colleagues2 used the
mediastinoscope to perform a pericardial window to treat a
recurrent pericarditis. Wittmoser3 used a single cannula to
performed sympathectomy and vagotomy, and recently my
group4 described the advantage of VATS-st to diagnose and
treat a wide range of thoracic diseases. In some circum-
stances the use of VATS-st avoids multiple skin incisions
for positioning of trocars, thus decreasing the risk of inter-
costal nerve damage and postoperative chest pain.
Several factors that can influence the outcome of a
VATS-st technique operation. First, the indications for the
operation must fit in a “noncomplex thoracic diseases”
classification. Second, the trocar must be flexible. Third, the
location where the trocar is inserted must be appropriate
(based on chest radiographs and computed tomographic
scan). The strategic position of the trocar will lead to a
successful operation. Although the flexible port was placed
posteriorly in 3 patients with empyema, I do not advocate
the insertion of the trocar through the latissimus dorsi be-
cause the intercostal space is smaller, and the chest tube also
has problems of kinking and causing discomfort.
In pleural effusion cases RFTs should be performed after
thoracocentesis. Nevertheless, when the operation is per-
formed with the patient under local anesthesia and sedation,
I do not recommend evacuating the fluid before the opera-
tion. I agree with Rusch and Mountain that in cases of
pleural effusion, patients can tolerate the procedure under
local anesthesia and sedation extremely well, because these
patients are accustomed to living their life with a partially
collapsed lung.1 It is also advisable to perform pleurodesis
without a definitive diagnosis in patients older than 80 years
with recurrent pleural effusion. This approach was used in 4
patients. Simple and loculated pleural effusion required
different operative and anesthesia times (P  .004), dem-
onstrating the complexity of the disease and leading to an
appropriate type of anesthesia and surgery. Malignant pleu-
ral effusion is best treated by thoracoscopic techniques.7,8 I
generally prefer talc pleurodesis instead of a long-term
dwelling pleural catheter9 because the latter leads to patient
discomfort due to daily maintenance. By using VATS-st, it
is easy to grasp the tip of the cannula of the talc spreader to
guide stratification of the talc on the “blind” surface of the
lung. The posterior and mediastinal surfaces of the lobes can
be exposed via a 5-mm endoscopic tampon. Talc is rou-
tinely administered in patients with trapped lobe to permit
the adhesion between the parietal and visceral pleura of the
remaining lung. The use of the pleuroperitoneal shunt or
long-term indwelling pleural catheter is reserved for those
patients with a trapped lung.9-11
Malignant pericardial effusion is an indication for
VATS-st, except in patients with a previous pneumonec-
Figure 2. A large mass in the anterior mediastinum is associated
with left pleural effusion. Biopsies of the mass and the simulta-
neous treatment of the effusion with talc were performed.
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tomy in whom a pericardioperitoneal shunt would be the
preferred technique.12
Mediastinal masses need a selective approach for diag-
nosis.13 Recently, it has been demonstrated that a thoraco-
scopic approach is indicated in some instances.14,15 I do not
advocate the transpleural biopsy of mediastinal masses be-
cause of the risk of disseminating the tumor into the pleural
cavity. Nevertheless, when a large undiagnosed mass of the
anterior mediastinum (Figure 2) is associated with pleural
effusion, VATS-st allows simultaneous biopsies of the me-
diastinal tumor and definitive treatment of the pleural effu-
sion. I speculate that mediastinal mass and pleural effusion
may be associated, and I consider the latter a metastatic
expression of the mass. It was discovered that the parietal
pleura was already invaded by the mediastinal tumor in
these patients. Furthermore, catastrophic complications of
difficult mediastinoscopies can be avoided.16
It has already been demonstrated that stage II empyema
is well treated with thoracoscopy by disruption of the locu-
lations and complete drainage of the infected space,17 as
confirmed in my experience. Although empyema was diag-
nosed preoperatively in 5 patients, the final diagnosis of
empyema was confirmed in 15 patients on the basis of
intraoperative findings, pleural biopsies, and cultural anal-
ysis of the pleural fluid. In some circumstances, localized
lung “decortication” can also be performed. As confirmed
by Hollaus and colleagues,18 if a “simple” pleural empyema
develops after pneumonectomy, the pleural cavity can be
sterilized by a thoracoscopic approach, avoiding further
invasive procedures.19,20
The following limitation of this study must be kept in
mind: this trial is not a comparison of VATS-st and the
standard port technique, and this creates the potential for
criticism in technique selection. Further investigative work
may be required to confirm the advantages and the potential
shortcomings of the VATS-st over several 5-mm incisions.
In conclusion, VATS-st is simple, effective, and benefi-
cial for all patients in the diagnosis and treatment of non-
complex diseases of the chest. Furthermore, with this new-
est type of technologically advanced instrumentation, it is
possible to conduct simple intrathoracic procedures without
using additional ports.
I acknowledge Kim Nguyen, PharmD, and Arnold Estrada,
PharmD, for excellent assistance. I am also much obliged to the
medical and nursing staff of the thoracic surgery unit at Tomaselli
Hospital, Catania, Italy.
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